Atlas Trials

Compassionate Use of Dupilumab

Clinical trial NCT04776694 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT04776694
Sponsor
Regeneron Pharmaceuticals
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Type 2 Inflammatory Disorders

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.